A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.
Malaria elimination will require interventions that prevent parasite transmission from the human host to the mosquito. Experimentally, this is usually determined by the expensive and laborious Plasmodium falciparum standard membrane feeding assay (PfSMFA), which has limited utility for high-throughp...
Principais autores: | Ruecker, A, Mathias, D, Straschil, U, Churcher, T, Dinglasan, R, Leroy, D, Sinden, R, Delves, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
American Society for Microbiology
2014
|
Registros relacionados
-
Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions
por: Delves, M, et al.
Publicado em: (2016) -
Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.
por: Delves, M, et al.
Publicado em: (2013) -
Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages
por: Michael Delves, et al.
Publicado em: (2019-09-01) -
Fueling open innovation for malaria transmission-blocking drugs: hundreds of molecules targeting early parasite mosquito stages
por: Delves, M, et al.
Publicado em: (2019) -
Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.
por: Joël Lelièvre, et al.
Publicado em: (2012-01-01)